Tag: Macular Degeneration
Odds of Prior Migraine Up for Patients With Neovascular AMD
Odds of prior migraine increased for those with neovascular AMD versus propensity score-matched controls
Trials Show Promise for Intravitreal Faricimab in Retinal Disease
Faricimab noninferior to aflibercept for visual acuity gains in neovascular age-related macular degeneration, diabetic macular edema
Aqueous Biomarkers May Help Predict Treatment Response in nvAMD
Treated patients who required less frequent anti-VEGF injections had increased apolipoprotein B100
Smoking, Alcohol Intake Tied to Age-Related Macular Degeneration
Findings based on mendelian randomization for genetically predicted smoking initiation, alcohol intake
First Biosimilar Approved for Macular Degeneration, Other Eye Conditions
Biosimilar to Lucentis approved to treat neovascular age-related macular degeneration, macular edema, myopic choroidal neovascularization
Air Pollution May Up Risk for Age-Related Macular Degeneration
Exposure to different pollutants including PM2.5, NO2, NOx linked to differences in retinal layer thickness
Anti-VEGF Therapy May Aid Visual Acuity in Some nAMD Patients
Useful visual acuity preserved for about 20 percent of patients over their average remaining lifetime
Levodopa Benefits Neovascular Age-Related Macular Degeneration
Levodopa is safe and well-tolerated, improves visual outcomes, and delays anti-VEGF treatment
AI Model Predicts Risk for Age-Related Macular Degeneration
Algorithm based on retinal photographs plus lifestyle (diet and smoking) and demographic data
Visit Adherence, Visual Acuity Linked in Macular Degeneration
Late, very late groups saw fewer letters than patients in on-time group for two measures of visit adherence
